CenExel Sold by Webster Equity Partners with Reed Smith's Guidance
Deal News | Apr 16, 2025 | Reed Smith
Webster Equity Partners has completed the sale of CenExel, a prominent clinical trial site network known for its specialization in complex therapeutic areas. Despite the sale, Webster Equity Partners will maintain a minority interest in the company, thus enabling continued involvement in its operations and future growth. Reed Smith, serving as legal advisors to Webster Equity Partners, played a significant role in ensuring the smooth execution of the transaction. Partners Nicole Aiken-Shaban and Carol Loepere, along with counsel Sarah Thompson Schick and associates Taber Reuter and Seb Dugmeoglu, constituted the Reed Smith team that guided the deal. This transaction is a strategic decision for Webster Equity Partners, allowing CenExel to further its mission of delivering advanced clinical research facilities to leading pharmaceutical companies.
Sectors
- Healthcare
- Private Equity
Geography
- United States – CenExel provides clinical trial services within the United States, and Webster Equity Partners is based in the U.S.
Industry
- Healthcare – CenExel operates within the healthcare industry, specifically in clinical trials, focusing on complex therapeutic areas.
- Private Equity – Webster Equity Partners is involved in private equity, providing investment and retaining minority stakes in portfolio companies.
Financials
- Not Disclosed – The financial terms of the transaction involving the sale of CenExel by Webster Equity Partners have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| CenExel | Target Company | Company | A leading clinical trial site network specializing in complex therapeutic areas. |
| Webster Equity Partners | Vendor | Company | A private equity firm that sold its majority stake in CenExel while retaining a minority interest. |
| Reed Smith | Legal Advisor | Company | A law firm that advised Webster Equity Partners on the sale of CenExel. |
| Nicole Aiken-Shaban | Lead Partner in Transaction | Person | Partner at Reed Smith who led the health care regulatory counsel team on the transaction. |
| Carol Loepere | Partner | Person | Partner at Reed Smith involved in the transaction. |
| Sarah Thompson Schick | Counsel | Person | Counsel at Reed Smith involved in the transaction. |
| Taber Reuter | Associate | Person | Associate at Reed Smith involved in the transaction. |
| Seb Dugmeoglu | Associate | Person | Associate at Reed Smith involved in the transaction. |